| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Faith L. Charles is Director at ABEO and has filed Form 4s across 3 companies. Faith L. Charles's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $793K at current prices.
Historically, Faith L. Charles's trades have earned a middling insider score of 53/100 across 4 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +6.9%.
The biggest single holding is ABEO (~$750K) as Director. The ABEO filings lean toward selling, a net 11,518 shares.
Faith L. Charles has 22 Form 4 filings on record from May 2021 to May 2026, across 4 companies: Director at CNS Pharmaceuticals (CNSP), 2022–2026; Director at Abeona Therapeutics (ABEO), 2021–2026; Director at CDT Equity (CDT), 2023–2025, and 1 more.
The 25 reported transactions were 11 stock awards, 10 option or other derivative awards, 2 open-market purchases and 2 open-market sales.
Counted by filing, the open-market trades come to 2 purchases worth about $59K and 2 sales worth about $104K.
The largest open-market purchase was 7,100 shares of CNSP at an average $4.79 on May 18, 2026, about $34K.
The largest open-market sale was 10,738 shares of ABEO at an average $5.86 on July 9, 2025, about $63K.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | CNSP Cns Pharmaceuticals, Inc. | Director | Buy | 7,100 | $4.79 | $34,001.90 | New | +14.6% | - | |
| Jul 9, 2025 | ABEO Abeona Therapeutics Inc. | Director | Sell | 10,738 | $5.86 | $62,878.51 | -7.2% | -9.9% | - | |
| Apr 26, 2024 | ABEO Abeona Therapeutics Inc. | Director | Buy | 7,550 | $3.28 | $24,764.00 | +10.7% | +54.3% | +63.5% | |
| Sep 27, 2023 | ABEO Abeona Therapeutics Inc. | Director | Sell | 8,330 | $4.91 | $40,923.62 | -10.5% | +28.5% | +49.7% |